According to a new study, hydroxychloroquine does not prolong the illness associated with COVID-19, while increased doses of Zithromax contributes to quicker recovery. One America’s Caitlin Sinclair has more on those findings.
Awareness of ivermectin’s efficacy and its adoption by physicians worldwide to successfully treat COVID-19 have grown exponentially over the past several months. Oddly, however, even as the clinical trials data and successful ivermectin treatment experiences continue to mount, so too have the criticisms and outright recommendations against the use of ivermectin by the vast majority, though not all, of public health agencies (PHA), concentrated largely in North America and Europe.
The Front Line COVID-19 Critical Care Alliance (FLCCC) and other ivermectin researchers have repeatedly offered expert analyses to respectfully correct and rebut the PHA recommendations, based on our deep study and rapidly accumulated expertise “in the field” on the use of ivermectin to treat COVID-19. These rebuttals were publicized and provided to international media for the education of providers and patients across the world. Our most recent response to the European Medicines Agency (EMA) and others recommendation against use can be found on the FLCCC website here.
America’s Frontline Doctors Simone Gold, a veteran medical physician, provides a detailed overview of the propaganda and media disinformation surrounding the COVID19 virus pandemic, COVID remedies and vaccinations.